Takahiro Kojima

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database

T. Habuchi, N. Tsuchiya, C. Ohyama, 2023, Cancer medicine.

Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study

N. Hinata, M. Miyake, K. Numakura, 2023, Scientific reports.

A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell Carcinoma

W. Obara, S. Hamamoto, N. Nakaigawa, 2021, AntiCancer Research.